Back to today’s briefing

Story perspectives

Q3 Earnings Surge: GeneDx, Amazon, and Meta Shine

10/26/2025

50 8 Full Breakdown

Summary

Story summary

GeneDx is expected to report a 950% year-over-year earnings increase in the third quarter.
Guardant Health anticipates a narrower loss for the quarter.
Amazon's third-quarter earnings will focus on its cloud business, with 18% projected growth in Amazon Web Services sales.
Meta Platforms expects strong advertising sales but faces competition from AI apps.
Novartis and Eli Lilly will discuss drug pricing strategies amid tariff concerns.

History

Historical Context

The dot-com bubble burst in 2000, following a decade of rapid internet growth and inflated stock valuations, leading to a market crash that resulted in $5 trillion in investor losses. Companies like Amazon, which reported $7.8 billion in sales that year, shifted focus to profitability. Today, firms like GeneDx and Guardant Health face similar pressures amid ongoing discussions on corporate accountability and drug pricing.

1 of 2

Story summary

GeneDx is expected to report a 950% year-over-year earnings increase in the third quarter.
Guardant Health anticipates a narrower loss for the quarter.
Amazon's third-quarter earnings will focus on its cloud business, with 18% projected growth in Amazon Web Services sales.
Meta Platforms expects strong advertising sales but faces competition from AI apps.
Novartis and Eli Lilly will discuss drug pricing strategies amid tariff concerns.

1 / 2